Posts

Social Media Helps Florida Teachers Connect, Inspire And Hone Their Craft

Social Media Helps Florida Teachers Connect, Inspire And Hone Their Craft
Lutz Elementary School teacher Mike Meiczinger noticed some parents weren't using the class web site to keep track of what their students were doing. … She scours Pinterest for ideas and articles, photos and other materials to use in the classroom …
Read more on StateImpact Florida

Healing outside the box
“There were so many really great ideas and teams here, I'm just really happy right now,” said Benjamin Brush, a student at Harvard Medical School (HMS) and a member of the VACU Scan team. “This money will speed up our implementation process,” said …
Read more on Harvard Gazette

Start it up! Budding entrepreneurs to compete next week
The group then divides into small teams, each spending the rest of the weekend focusing on a single business idea and developing a proof of concept, demo or finished product. Mentors help fine-tune the idea into a “working company” with potential profits.
Read more on Mississippi Business Journal (blog)

Dr. Tomasz Sablinski to Deliver Keynote at 2012 OpenClinica Conference


Waltham, Massachusetts (PRWEB) February 13, 2012

Headlining this years OpenClinica Global Conference is Dr. Tomasz Sablinski, a leading clinical research innovator who is challenging the current model of drug development. Dr. Sablinski will talk about how barriers to delivering new medical treatments via clinical development can be overcome by borrowing from contemporary concepts of transparency, crowd sourcing, and open innovation.

Dr. Sablinskis perspective reflects his 30+ years working as a practicing physician, basic researcher, drug developer, investor, and entrepreneur. During this time, has served as a researcher at Harvard Medical School, a Medical Director at Parexel, VP of Clinical Development at Novartis, and Head of Development and Managing Director at private equity firm Celtic Therapeutics.

According to Dr. Sablinski, The emerging clinical development crisis requires a re-thinking of the entire process. Those organizations flexible enough to adapt by redesigning the way clinical trials are conceived and conducted using advances in communications and telemedicine, along with open innovation principles, will, I believe, prevail in the long run.

Dr. Sablinski believes we are at an inflection point–the persistent poor productivity of existing clinical approaches provides a unique opportunity for bringing much- needed innovation to the clinical trials industry.

We are thrilled to have Dr. Tomasz Sablinski deliver the keynote address at this years OpenClinica conference, said Ben Baumann, Chair of the OpenClinica Conference Committee. His bold ideas will be sure to challenge many of our current assumptions in thought-provoking, even controversial ways. He is not afraid to question the status quo, and seeks to encourage much of the same type of disruptive innovation that OpenClinica strives to bring to clinical research.

More information about the 2012 OpenClinica Conference is available online at https://community.openclinica.com/conference.

About the 2012 OpenClinica Conference